MYCT1 in cancer development: Gene structure, regulation, and biological implications for diagnosis and treatment.

Myc target 1 (MYCT1), located at 6q25.2, is a crucial player in cancer development. While widely distributed in cells, its subcellular localization varies across different cancer types. As a novel c-Myc target gene, MYCT1 is subject to regulation by multiple transcription factors. Studies have revealed aberrant expression of MYCT1 in various cancers, impacting pivotal biological processes such as proliferation, apoptosis, migration, genomic instability, and differentiation in cancer cells. Additionally, MYCT1 plays a critical role in modulating tumor angiogenesis and remodeling tumor immune responses within the tumor microenvironment. Despite certain debated functions, MYCT1 undeniably holds significance in cancer development. In this review, we comprehensively examine the relationship between MYCT1 and cancer, encompassing gene structure, regulation of gene expression, gene mutation, and biological function, with the aim of providing valuable insights for cancer diagnosis and treatment. [Display omitted] • MYCT1 , a novel c-Myc target gene, is a crucial player in cancer development. • It affects pivotal biological processes in cancer cells. • It has shown the potential to function as an oncogene or as a tumor suppressor. • The role of MYCT1 in cancer may provide new ideas for cancer diagnosis and treatment. [ABSTRACT FROM AUTHOR]